Amneal Pharmaceuticals Inc (NYSE:AMRX)

4.84
Delayed Data
As of Jul 23
 +0.03 / +0.62%
Today’s Change
3.45
Today|||52-Week Range
7.45
+5.91%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line39.0M-472.0M-469.3M-201.3M
 
 
 
 
 
Depreciation68.6M88.3M109.4M137.4M
 
 
 
 
 
Total Other Cash Flow64.0M588.1M380.3M261.6M
 
 
 
 
 
Funds From Operations142.1M77.0M95.3M188.3M
 
 
 
 
 
Funds From/For Other Operating Expenses70.2M2.4M11.1M-7.0M
 
 
 
 
 
Net Cash Flow - Operating Activities71.9M74.6M84.2M195.3M
 
 
 
 
 
 
InvestingDecrease In Investments200.1M0.000.000.00
 
 
Capital Expenditures-25.2M-49.4M-26.7M-83.1M
 
 
 
 
 
Fixed Asset Disposal59.5M1.4M9.1M25.7M
 
 
 
 
 
Net Assets From Acquisitions -691.3M-585.8M-121.0K-336.4M
 
 
 
 
 
Other Investing - Uses-4.8M-4.8M-4.8M0.00
 
 
 
 
Other Investing - Sources--15.0M12.9M0.00
 
 
 
Net Cash Flow Investing-467.5M-627.1M-9.7M-407.8M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00-75.0M
 
 
Long Term Borrowings998.1M388.1M0.001.3B
 
 
 
 
Long Term Debt Reduction-435.0M-5.0M-70.0M-709.3M
 
 
 
 
 
Net Proceeds Stock Sale99.8M9.2M1.4M31.5M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.00-183.0M
 
 
Cash Dividends Paid - Total0.000.000.00-183.0M
 
 
Other Sources - Financing5.5M0.000.000.00
 
 
Other Uses - Financing147.0M589.0K5.0M35.5M
 
 
 
 
 
Net Cash Flow - Financing521.4M391.8M-73.7M354.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-298.0K494.0K773.0K-670.0K
 
 
 
 
 
 
Net Change In Cash125.8M-160.7M872.0K141.5M